Heron Therapeutics (HRTX) P/S US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 10.4 | 2.53 | 1.85 | 1.62 | 1.40 | 1.21 | ||
| Changes by years, y/y, % | -52% | -76% | -27% | -13% | -13% | -42.2% | |||
Heron Therapeutics. P/S
Heron Therapeutics. P/S, changes, %
Heron Therapeutics (HRTX) P/S US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/S | ? | 2.27 | 2.13 | 1.38 | 1.40 | 1.01 | 1.21 | |
| Changes by years, y/y, % | -28% | -46% | -37% | -14% | -56% | |||
| Changes by quarters, q/q, % | +40% | -6% | -35% | +1% | -28% | |||